Blood Analyzers in Georgia

Macopharma, founded in 1977, is a major international player in blood processing and transfusion medicine. The company develops and manufactures a comprehensive range of blood processing solutions, combining disposables, equipment, software, and processing guidelines to support healthcare professionals in producing safer, higher-quality blood components. The company operates 3 manufacturing facilities across its global network of 15 subsidiaries serving 84 countries with approximately 1,911 employees. Macopharma specializes in blood component preparation, storage, and testing solutions, with documented expertise in red blood cell concentrate preservation (DEHT/PAGGSM and DEHP/SAGM containers), platelet processing (buffy coat-derived platelets), and hemolysis measurement methodologies. The company maintains active research and development collaborations focused on blood safety, cell therapy manufacturing supply chains, and sustainable blood industry practices. Products address blood bank operations, transfusion services, and cellular therapy manufacturing. The company emphasizes quality assurance, regulatory compliance, and environmental responsibility through documented CSR commitments and life cycle assessment initiatives. Macopharma's innovation framework (INNOV by Macopharma) involves cross-functional teams spanning R&D, Manufacturing, Medical Affairs, Marketing, Regulation, and Sales to develop solutions aligned with blood safety and sustainability standards.

SEBIA is a global in vitro diagnostics company specializing in capillary electrophoresis and protein analysis systems for clinical laboratories. The company manufactures and distributes a comprehensive portfolio of automated instruments, reagent assays, and software solutions for the diagnosis and monitoring of chronic and metabolic diseases, including multiple myeloma, hemoglobinopathies, autoimmune disorders, genetic diseases, and infectious diseases. SEBIA's product range includes standalone and integrated workcell configurations of electrophoresis instruments (such as the Capillaris 3 TERA system) paired with corresponding serum, urine, and specialized protein electrophoresis tests. The company operates in over 120 countries with approximately 20,000 installed instruments worldwide and employs over 1,300 staff. SEBIA offers complementary services including data analysis and interpretation software, Sebia Lean Service (laboratory management and optimization), Sebia Academy (scientific training and education), and Sebia Service (technical and scientific customer support). The company positions itself as providing solutions that translate patient biomarkers into clinically actionable diagnostic information, supporting laboratory efficiency and patient outcomes in clinical chemistry and immunology.

Core Technology Co., Ltd. is a subsidiary of CorDx Union, an international medical diagnostics group established in 2006. The company specializes in in vitro diagnostic (IVD) test kits and point-of-care (POC) testing solutions, serving over 120 countries with more than 1 billion users globally. Product portfolio includes fertility tests, respiratory infectious disease diagnostics, sexual transmitted disease screening, infectious disease panels, cardiac markers, tumor markers, drug-of-abuse screening, and health monitoring tests including blood glucose measurement systems. The company maintains FDA, CE (Conformité Européenne), and NMPA (National Medical Products Administration, China) regulatory certifications for its diagnostic products. Core Technology operates R&D centers, manufacturing facilities, and sales platforms across the United States (California and Georgia headquarters), United Kingdom, Dubai, and Singapore. Manufacturing and quality capabilities are centered in Beijing with industrial facilities exceeding 100,000 square meters. The company participates in major international medical trade shows including Medica, Medlab Asia, and Hospitalar, indicating active engagement in the global clinical diagnostics market.

CorDx Labs is a biotechnology company specializing in in vitro diagnostic (IVD) products for point-of-care and over-the-counter use. With 18+ years of industry experience, CorDx operates a vertically integrated supply chain with manufacturing facilities across the United States and internationally, serving 170+ countries through a global network of 700+ partners. The company manufactures and distributes a portfolio of 1,000+ diagnostic products spanning infectious disease testing (including multiplex rapid tests for flu, COVID-19, and RSV), reproductive and fertility testing, molecular diagnostics, and pet diagnostics. CorDx also offers contract manufacturing services for diagnostic products across multiple therapeutic areas, leveraging advanced quality and compliance systems to ensure operational excellence.